Literature DB >> 22919065

Adverse cardiovascular outcomes of corticosteroid excess.

Eduardo Pimenta1, Martin Wolley, Michael Stowasser.   

Abstract

Corticosteroid excess is associated with adverse cardiovascular outcomes. Patients with Cushings's syndrome, either caused by endogenous or exogenous glucocorticoid excess, and patients with primary aldosteronism have increased cardiovascular risk. The increase in risk is mediated partly by traditional cardiovascular risk factors including hypertension and metabolic syndrome but also by other, less well-characterized mechanisms. Experimental and human studies have shown that target organ deterioration induced by aldosterone depends on concomitant high dietary salt intake. Key ongoing research questions that warrant further study by both clinical and experimental approaches include the following: 1) beyond inducing the metabolic syndrome, what are the mechanisms by which glucocorticoids are associated with excess cardiovascular risk, 2) what are the cellular pathways by which excessive mineralocorticoid receptor activation brings about cardiovascular and renal damage, and 3) why is salt critical in this process?

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22919065     DOI: 10.1210/en.2012-1573

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

2.  Effects of HIP in protection of HSP70 for stress-induced cardiomyocytes injury and its glucorticoid receptor pathway.

Authors:  Zhang ZhiQing; Wang XinXing; Gong Jingbo; Zhan Rui; Gao Xiujie; Zhao Yun; Wu Lei; Leng Xue; Qian LingJia
Journal:  Cell Stress Chaperones       Date:  2014-05-01       Impact factor: 3.667

3.  Corticosteroid Receptors in Cardiac Health and Disease.

Authors:  Jessica R Ivy; Gillian A Gray; Megan C Holmes; Martin A Denvir; Karen E Chapman
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery.

Authors:  Camilly P Pires de Mello; Carlos Carmona-Moran; Christopher W McAleer; Julian Perez; Elizabeth A Coln; Christopher J Long; Carlota Oleaga; Anne Riu; Reine Note; Silvia Teissier; Jessica Langer; James J Hickman
Journal:  Lab Chip       Date:  2020-01-23       Impact factor: 6.799

5.  Associations of Serum Cortisol with Cardiovascular Risk and Mortality in Patients Referred to Coronary Angiography.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Martin H Keppel; Martin R Grübler; Nicolas Verheyen; Balazs Odler; Andreas Meinitzer; Jakob Voelkl; Winfried März
Journal:  J Endocr Soc       Date:  2021-02-10

Review 6.  The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.

Authors:  Ekaterina A Lesovaya; Daria Chudakova; Gleb Baida; Ekaterina M Zhidkova; Kirill I Kirsanov; Marianna G Yakubovskaya; Irina V Budunova
Journal:  Oncotarget       Date:  2022-02-18

7.  Corticosteroids increase intracellular free sodium ion concentration via glucocorticoid receptor pathway in cultured neonatal rat cardiomyocytes.

Authors:  Daisuke Katoh; Kenichi Hongo; Keiichi Ito; Takuya Yoshino; Yosuke Kayama; Makoto Kawai; Taro Date; Michihiro Yoshimura
Journal:  Int J Cardiol Heart Vessel       Date:  2014-03-13

8.  NADPH oxidases and HIF1 promote cardiac dysfunction and pulmonary hypertension in response to glucocorticoid excess.

Authors:  Damir Kračun; Mathieu Klop; Anna Knirsch; Andreas Petry; Ivan Kanchev; Karel Chalupsky; Cordula M Wolf; Agnes Görlach
Journal:  Redox Biol       Date:  2020-04-11       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.